down arrow

Nureca

  • Market Cap: Micro Cap
  • Industry: Medical Equipment/Supplies/Accessories
  • ISIN: INE0DSF01015
  • NSEID: NURECA
  • BSEID: 543264
INR
214.00
6.8 (3.28%)
BSENSE

Apr 11, 12:51 PM

BSE+NSE Vol: 1.94 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.94 k (-70.55%) Volume

Shareholding (Dec 2024)

FII

0.36%

Held by 2 FIIs

DII

0.04%

Held by 0 DIIs

Promoter

64.06%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • The company has been able to generate a Return on Equity (avg) of 6.51% signifying low profitability per unit of shareholders funds
2

Flat results in Dec 24

3

Stock is technically in a Bearish range

4

Risky - Negative EBITDA

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Medical Equipment/Supplies/Accessories

stock-summary
Market cap

INR 214 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

53

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.12

stock-summary
Return on Equity

-1.44%

stock-summary
Price to Book

1.07

Revenue and Profits (1 Year):
Net Sales:
26 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-3 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-29.13%
0%
-29.13%
1 Year
-26.56%
0%
-26.56%
2 Years
-36.07%
0%
-36.07%
3 Years
-84.83%
0%
-84.83%
4 Years
-74.66%
0.32%
-74.34%
5 Years
0%
0%
0.0%

Latest dividend: 3 per share ex-dividend date: Feb-24-2022

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-18.45%
EBIT Growth (5y)
-171.28%
EBIT to Interest (avg)
11.11
Debt to EBITDA (avg)
0.11
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.87
Tax Ratio
19.64%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.40%
ROCE (avg)
25.42%
ROE (avg)
6.51%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
53
Price to Book Value
1.07
EV to EBIT
-11.82
EV to EBITDA
-13.99
EV to Capital Employed
1.08
EV to Sales
1.94
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-9.27%
ROE (Latest)
-1.44%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Bearish
Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 2 FIIs (0.36%)

Promoter with highest holding

Saurabh Goyal (31.67%)

Highest Public shareholder

None

Individual Investors Holdings

33.27%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -15.17% vs 53.87% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -483.33% vs -128.92% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "26.46",
          "val2": "31.19",
          "chgp": "-15.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.02",
          "val2": "-2.36",
          "chgp": "-70.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.18",
          "val2": "0.27",
          "chgp": "-33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.80",
          "val2": "-0.48",
          "chgp": "-483.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-15.19%",
          "val2": "-7.57%",
          "chgp": "-7.62%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -2.13% vs -15.62% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -46.12% vs 131.20% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "51.46",
          "val2": "52.58",
          "chgp": "-2.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.72",
          "val2": "-1.52",
          "chgp": "-210.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.42",
          "val2": "0.20",
          "chgp": "110.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.18",
          "val2": "2.19",
          "chgp": "-46.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-9.17%",
          "val2": "-2.89%",
          "chgp": "-6.28%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 3.96% vs -16.81% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -168.64% vs 135.12% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "77.92",
          "val2": "74.95",
          "chgp": "3.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-8.74",
          "val2": "-5.78",
          "chgp": "-51.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.31",
          "chgp": "93.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.62",
          "val2": "2.36",
          "chgp": "-168.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-11.22%",
          "val2": "-7.71%",
          "chgp": "-3.51%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -17.42% vs -56.44% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 78.30% vs -118.35% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "91.93",
          "val2": "111.32",
          "chgp": "-17.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-10.21",
          "val2": "-15.01",
          "chgp": "31.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.49",
          "val2": "0.45",
          "chgp": "8.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.79",
          "val2": "-8.25",
          "chgp": "78.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-11.11%",
          "val2": "-13.48%",
          "chgp": "2.37%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
26.46
31.19
-15.17%
Operating Profit (PBDIT) excl Other Income
-4.02
-2.36
-70.34%
Interest
0.18
0.27
-33.33%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.80
-0.48
-483.33%
Operating Profit Margin (Excl OI)
-15.19%
-7.57%
-7.62%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -15.17% vs 53.87% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -483.33% vs -128.92% in Sep 2024

Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
51.46
52.58
-2.13%
Operating Profit (PBDIT) excl Other Income
-4.72
-1.52
-210.53%
Interest
0.42
0.20
110.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.18
2.19
-46.12%
Operating Profit Margin (Excl OI)
-9.17%
-2.89%
-6.28%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -2.13% vs -15.62% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -46.12% vs 131.20% in Sep 2023

Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
77.92
74.95
3.96%
Operating Profit (PBDIT) excl Other Income
-8.74
-5.78
-51.21%
Interest
0.60
0.31
93.55%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.62
2.36
-168.64%
Operating Profit Margin (Excl OI)
-11.22%
-7.71%
-3.51%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 3.96% vs -16.81% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -168.64% vs 135.12% in Dec 2023

Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
91.93
111.32
-17.42%
Operating Profit (PBDIT) excl Other Income
-10.21
-15.01
31.98%
Interest
0.49
0.45
8.89%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.79
-8.25
78.30%
Operating Profit Margin (Excl OI)
-11.11%
-13.48%
2.37%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -17.42% vs -56.44% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 78.30% vs -118.35% in Mar 2023

stock-summaryCompany CV
About Nureca Ltd stock-summary
stock-summary
Nureca Ltd
Micro Cap
Medical Equipment/Supplies/Accessories
Nureca Limited was formerly incorporated as Nureca Private Limited in India on 02 November 2016 under the provisions of Companies Act, 2013. The Company got converted from Private Limited Company to a Public Limited Company with effect from 08 July 2020 and the name of Company was changed to Nureca Limited. The Company is engaged in the business of home healthcare and wellness products. The Company is engaged in the business of home healthcare and wellness products.
Company Coordinates stock-summary
Icon
No Company Details Available